Intracranial cellular schwannomas: a clinicopathological study of 20 cases

被引:14
作者
Costa, Felipe D'Almeida [1 ]
Dias, Tiago M. [1 ]
Lombardo, Kara A. [2 ]
Raghunathan, Aditya [3 ]
Giannini, Caterina [3 ]
Kenyon, Lawrence [4 ]
Saad, Ali G. [5 ]
Gokden, Murat [6 ]
Burger, Peter C. [2 ]
Montgomery, Elizabeth A. [2 ]
Rodriguez, Fausto J. [2 ,7 ]
机构
[1] AC Camargo Canc Ctr, Dept Anat Pathol, Sao Paulo, Brazil
[2] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21231 USA
[3] Mayo Clin, Dept Pathol, Rochester, MN USA
[4] Thomas Jefferson Univ Hosp, Dept Pathol, Philadelphia, PA 19107 USA
[5] Univ Mississippi, Dept Pathol, Jackson, MS 39216 USA
[6] Univ Arkansas, Dept Pathol, Little Rock, AR 72204 USA
[7] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA
关键词
cellular schwannoma; H3; K27me3; intracranial; MPNST; NF2; NERVE SHEATH TUMORS; SUZ12;
D O I
10.1111/his.13967
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims Cellular schwannoma is a specific subtype of schwannoma, prone to misinterpretation as a malignant neoplasm. Involvement of the intracranial compartment by these tumours is extremely rare. We aim to characterise this clinicopathological subgroup. Methods and results We identified a total of 20 cellular schwannomas with predominant intracranial involvement. The mean age of the patients at the time of surgery was 37 years (range = 16-81), with a slight female predominance (1.5:1 ratio). The most common sites were the eighth (n = 8) and fifth (n = 6) cranial nerves. Three tumours involved the anterior cranial fossa/olfactory groove, and a single case involved the glossopharyngeal nerve. All tumours met established criteria for cellular schwannoma, and were composed of interlacing fascicles of spindle cells lacking Verocay bodies with minimal Antoni B pattern and variable chronic inflammation and foamy histiocytes. Rare findings included haemosiderin deposition (n = 6), necrosis (n = 4), brisk mitotic activity (>10 mitoses per 10 high-power fields) (n = 2), focal epithelioid morphology (n = 2), myxoid areas (n = 2), neuroblastoma-like pattern (n = 1) and granular cells (n = 1). Immunohistochemical stains demonstrated expression of Schwann cell markers (S100 protein, SOX10, collagen IV) and preserved H3 K27 trimethylation in all cases tested. Fourteen patients had postoperative follow-up, ranging from 2 months to 21 years (mean = 66 months). In patients with follow-up, local recurrence/persistence developed in six cases; five tumours were initially incompletely resected. No metastatic disease or deaths were reported. Conclusions Intracranial cellular schwannomas share morphological and immunophenotypical features with cellular schwannomas at others sites may demonstrate locally aggressive growth but appear to lack metastatic potential.
引用
收藏
页码:275 / 282
页数:8
相关论文
共 28 条
[1]  
CARPENTER PM, 1992, ARCH PATHOL LAB MED, V116, P1083
[2]  
CASADEI GP, 1995, CANCER, V75, P1109, DOI 10.1002/1097-0142(19950301)75:5<1109::AID-CNCR2820750510>3.0.CO
[3]  
2-M
[4]   Thalamic intracerebral schwannoma: case report [J].
de Andrade, GC ;
Neto, MAD ;
Braga, FM .
ARQUIVOS DE NEURO-PSIQUIATRIA, 2002, 60 (2A) :308-313
[5]   CELLULAR SCHWANNOMAS OF THE INTRACRANIAL AND INTRASPINAL COMPARTMENT - MORPHOLOGICAL AND IMMUNOLOGICAL CHARACTERISTICS COMPARED WITH CLASSICAL BENIGN SCHWANNOMAS [J].
DERUAZ, JP ;
JANZER, RC ;
COSTA, J .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1993, 52 (02) :114-118
[6]   Cellular schwannoma of the abducens nerve: Case report and review of the literature [J].
Erlich, Sarah A. ;
Tymianski, Michael ;
Kiehl, Tim-Rasmus .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2009, 111 (05) :467-471
[7]   Endoscopic endonasal transsphenoidal removal of an intra-suprasellar Schwannoma mimicking a pituitary adenoma [J].
Esposito, F ;
Cappabianca, R ;
De Caro, MD ;
Cavallo, LM ;
Rinaldi, C ;
de Divitiis, E .
MINIMALLY INVASIVE NEUROSURGERY, 2004, 47 (04) :230-234
[8]  
FLETCHER CDM, 1987, HISTOPATHOLOGY, V11, P21
[9]  
Fletcher CDM, 2013, WHO Classification of Tumours Series, V5
[10]  
FULLER GN, 1990, CLIN NEUROPATHOL, V9, P279